766 Toward safe, systemic delivery of synthetic TLR7/8 agonists using Bottlebrush Prodrugs (BPDs)

• Bin Liu,
• Jeremiah Johnson,
• Stefani Spranger,
• Timothy Fessenden,
• Lauren Milling,
• Darrell Irvine,
• Sachin Bhagchandani

Affiliations

Bin Liu

Xinhe Foundation, Beijing, China

Jeremiah Johnson

Neurosurgery, Baylor College of Medicine, Houston, Texas, USA

Stefani Spranger

Koch Institute for Integrative Cancer Research at MIT, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA

Timothy Fessenden

Koch Institute, Cambridge, MA, USA

Lauren Milling

Massachusetts Institute of Technology, Cambridge, MA, USA

Darrell Irvine

Massachusetts Institute of Technology, Cambridge, MA, USA

Sachin Bhagchandani

Massachusetts Institute of Technology, Cambridge, MA, United States